Inventor

MCKERRACHER LISA

US20 patents

⚠️ This page may combine multiple inventors who share the name “MCKERRACHER LISA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MCKERRACHER LISA

BIOAXONE BIOSCIENCES INC

Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitors

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Rho kinase inhibitor ba-1049 (r) and active metabolites thereof

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors

Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Kinase inhibitors for treatment of disease

Treatment of CNS injury with RNAi therapeutics

C3 fusion protein and methods of making and using thereof

Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors

BIOAXONE THERAPEUTIQUE INC

4-substituted piperidine derivatives

Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions

ADP-ribosyl transferase fusion proteins, pharmaceutical compositions, and methods of use

ADP-ribosyl transferase fusion variant proteins

Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions

MCKERRACHER LISA

Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof

Methods for making and delivering Rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof

UNIV MONTREAL

(+)-Trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesion